Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 309 studies with search of: | "Trastuzumab" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer
|
||||
2 | Terminated |
Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer
|
||||
3 | Recruiting |
Six vs 12 Months of Transtuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer
|
||||
4 | Active, not recruiting |
A Dose Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and HER2 Positive Female Patients
|
||||
5 | Recruiting |
The Synergism Or Long Duration (SOLD) Study
|
||||
6 | Recruiting |
A Study of the Efficacy and Safety of Trastuzumab-Mcc-DM1 vs. Trastuzumab (Herceptin®) and Docetaxel (Taxotere®) in Patients With Metastatic HER2-Positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease
|
||||
7 | Recruiting |
A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer
|
||||
8 | Recruiting |
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
|
||||
9 | Recruiting |
Trastuzumab Optimization Trial in Breast Cancer
|
||||
10 | Recruiting |
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
|
||||
11 | Active, not recruiting |
Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast
|
||||
12 | Recruiting |
Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-Positive Breast Cancer (Study P05048AM2)
|
||||
13 | Recruiting |
Efficacy and Safety Study Evaluating IPI-504 With Trastuzumab in Patients With Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer
|
||||
14 | Completed |
Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer
|
||||
15 | Active, not recruiting |
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
|
||||
16 | Completed |
Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients
|
||||
17 | Recruiting |
Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer
|
||||
18 | Recruiting |
Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Patients With HER2-Positive Breast Cancer
|
||||
19 | Recruiting |
Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients
|
||||
20 | Recruiting |
Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |